Working… Menu
Trial record 1 of 1 for:    NCT03703297
Previous Study | Return to List | Next Study

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy (ADRIATIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03703297
Recruitment Status : Active, not recruiting
First Posted : October 11, 2018
Last Update Posted : September 17, 2021
Information provided by (Responsible Party):